Depending on the cause of the disorder, hormone therapy or a blood-flow enhancing medication, like Viagra, may be appropriate. Bremelanotide (formerly PT-141) is being studied in clinical tests to increase<unk>  desire in women. In 2014, Palatin, the company developing the drug, announced the beginning of a Phase 3 clinical trial to determine its effectiveness.
Sexual arousal disorder
Hypoactive sexual desire disorder
Gratification disorder
Persistent genital arousal disorder
Psychosexual disorder
Female sexual arousal disorder
Sexual addiction
Sexual relationship disorder